Summary

The global Small Molecule Drug 3D Printing market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Small Molecule Drug 3D Printing refers to a technology that involves the use of 3D printing techniques to fabricate pharmaceuticals containing small molecule drugs. Unlike traditional manufacturing methods where drugs are typically produced in bulk as tablets or capsules with uniform dosages, 3D printing allows for the creation of personalized medicine and complex dosage forms on a patient-by-patient basis.
In 2025, the North America Small Molecule Drug 3D Printing market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Small Molecule Drug 3D Printing include Aprecia, FabRx, Multiply Labs, Merck KGaA, Triastek, MSD, AstraZeneca, TNO, Multiply Labs, DiHeSys, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Small Molecule Drug 3D Printing market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Aprecia
FabRx
Multiply Labs
Merck KGaA
Triastek
MSD
AstraZeneca
TNO
Multiply Labs
DiHeSys
Segment by Type
Material Extrusion
Binder Jetting
Powder Bed Fusion
Other
Segment by Application
Large-scale Production
Personalized Pharmaceutical
Concept Research and Technology Development
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Small Molecule Drug 3D Printing market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Small Molecule Drug 3D Printing value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Material Extrusion
1.2.3 Binder Jetting
1.2.4 Powder Bed Fusion
1.2.5 Other
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Large-scale Production
1.3.3 Personalized Pharmaceutical
1.3.4 Concept Research and Technology Development
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Small Molecule Drug 3D Printing Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Small Molecule Drug 3D Printing Market Share by Revenue, by Region (2021-2026)
2.4 Global Small Molecule Drug 3D Printing Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Small Molecule Drug 3D Printing Market Size and Prospective (2021-2032)
2.5.2 Europe Small Molecule Drug 3D Printing Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Small Molecule Drug 3D Printing Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global Small Molecule Drug 3D Printing Historical Market Size by Type (2021-2026)
3.2 Global Small Molecule Drug 3D Printing Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Small Molecule Drug 3D Printing

4 Breakdown Data by Application
4.1 Global Small Molecule Drug 3D Printing Historical Market Size by Application (2021-2026)
4.2 Global Small Molecule Drug 3D Printing Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Small Molecule Drug 3D Printing Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Small Molecule Drug 3D Printing Players by Revenue (2021-2026)
5.1.2 Global Small Molecule Drug 3D Printing Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Small Molecule Drug 3D Printing Revenue
5.4 Global Small Molecule Drug 3D Printing Market Concentration Analysis
5.4.1 Global Small Molecule Drug 3D Printing Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Small Molecule Drug 3D Printing Revenue in 2025
5.5 Global Key Players of Small Molecule Drug 3D Printing Head Offices and Areas Served
5.6 Global Key Players of Small Molecule Drug 3D Printing, Product and Application
5.7 Global Key Players of Small Molecule Drug 3D Printing, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Small Molecule Drug 3D Printing Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Small Molecule Drug 3D Printing Market Size by Type (2021-2026)
6.1.2.2 North America Small Molecule Drug 3D Printing Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Small Molecule Drug 3D Printing Market Size by Application (2021-2026)
6.1.3.2 North America Small Molecule Drug 3D Printing Market Share by Application (2021-2026)
6.1.4 North America Small Molecule Drug 3D Printing Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Small Molecule Drug 3D Printing Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Small Molecule Drug 3D Printing Market Size by Type (2021-2026)
6.2.2.2 Europe Small Molecule Drug 3D Printing Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Small Molecule Drug 3D Printing Market Size by Application (2021-2026)
6.2.3.2 Europe Small Molecule Drug 3D Printing Market Share by Application (2021-2026)
6.2.4 Europe Small Molecule Drug 3D Printing Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Small Molecule Drug 3D Printing Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Small Molecule Drug 3D Printing Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Small Molecule Drug 3D Printing Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Small Molecule Drug 3D Printing Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Small Molecule Drug 3D Printing Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Small Molecule Drug 3D Printing Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities

7 Key Player Profiles
7.1 Aprecia
7.1.1 Aprecia Company Details
7.1.2 Aprecia Business Overview
7.1.3 Aprecia Small Molecule Drug 3D Printing Introduction
7.1.4 Aprecia Revenue in Small Molecule Drug 3D Printing Business (2021-2026)
7.1.5 Aprecia Recent Development
7.2 FabRx
7.2.1 FabRx Company Details
7.2.2 FabRx Business Overview
7.2.3 FabRx Small Molecule Drug 3D Printing Introduction
7.2.4 FabRx Revenue in Small Molecule Drug 3D Printing Business (2021-2026)
7.2.5 FabRx Recent Development
7.3 Multiply Labs
7.3.1 Multiply Labs Company Details
7.3.2 Multiply Labs Business Overview
7.3.3 Multiply Labs Small Molecule Drug 3D Printing Introduction
7.3.4 Multiply Labs Revenue in Small Molecule Drug 3D Printing Business (2021-2026)
7.3.5 Multiply Labs Recent Development
7.4 Merck KGaA
7.4.1 Merck KGaA Company Details
7.4.2 Merck KGaA Business Overview
7.4.3 Merck KGaA Small Molecule Drug 3D Printing Introduction
7.4.4 Merck KGaA Revenue in Small Molecule Drug 3D Printing Business (2021-2026)
7.4.5 Merck KGaA Recent Development
7.5 Triastek
7.5.1 Triastek Company Details
7.5.2 Triastek Business Overview
7.5.3 Triastek Small Molecule Drug 3D Printing Introduction
7.5.4 Triastek Revenue in Small Molecule Drug 3D Printing Business (2021-2026)
7.5.5 Triastek Recent Development
7.6 MSD
7.6.1 MSD Company Details
7.6.2 MSD Business Overview
7.6.3 MSD Small Molecule Drug 3D Printing Introduction
7.6.4 MSD Revenue in Small Molecule Drug 3D Printing Business (2021-2026)
7.6.5 MSD Recent Development
7.7 AstraZeneca
7.7.1 AstraZeneca Company Details
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Small Molecule Drug 3D Printing Introduction
7.7.4 AstraZeneca Revenue in Small Molecule Drug 3D Printing Business (2021-2026)
7.7.5 AstraZeneca Recent Development
7.8 TNO
7.8.1 TNO Company Details
7.8.2 TNO Business Overview
7.8.3 TNO Small Molecule Drug 3D Printing Introduction
7.8.4 TNO Revenue in Small Molecule Drug 3D Printing Business (2021-2026)
7.8.5 TNO Recent Development
7.9 Multiply Labs
7.9.1 Multiply Labs Company Details
7.9.2 Multiply Labs Business Overview
7.9.3 Multiply Labs Small Molecule Drug 3D Printing Introduction
7.9.4 Multiply Labs Revenue in Small Molecule Drug 3D Printing Business (2021-2026)
7.9.5 Multiply Labs Recent Development
7.10 DiHeSys
7.10.1 DiHeSys Company Details
7.10.2 DiHeSys Business Overview
7.10.3 DiHeSys Small Molecule Drug 3D Printing Introduction
7.10.4 DiHeSys Revenue in Small Molecule Drug 3D Printing Business (2021-2026)
7.10.5 DiHeSys Recent Development

8 Small Molecule Drug 3D Printing Market Dynamics
8.1 Small Molecule Drug 3D Printing Industry Trends
8.2 Small Molecule Drug 3D Printing Market Drivers
8.3 Small Molecule Drug 3D Printing Market Challenges
8.4 Small Molecule Drug 3D Printing Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Small Molecule Drug 3D Printing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Small Molecule Drug 3D Printing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Small Molecule Drug 3D Printing Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Small Molecule Drug 3D Printing Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Small Molecule Drug 3D Printing Revenue Share by Region (2021-2026)
Table 6. Global Small Molecule Drug 3D Printing Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Small Molecule Drug 3D Printing Revenue Share Forecast by Region (2027-2032)
Table 8. Global Small Molecule Drug 3D Printing Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Small Molecule Drug 3D Printing Market Share by Revenue, by Type (2021-2026)
Table 10. Global Small Molecule Drug 3D Printing Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Small Molecule Drug 3D Printing Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Small Molecule Drug 3D Printing Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Small Molecule Drug 3D Printing Market Share by Revenue, by Application (2021-2026)
Table 15. Global Small Molecule Drug 3D Printing Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Small Molecule Drug 3D Printing Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Small Molecule Drug 3D Printing Applications
Table 18. Global Small Molecule Drug 3D Printing Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Small Molecule Drug 3D Printing Market Share by Players (2021-2026)
Table 20. Global Top Small Molecule Drug 3D Printing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug 3D Printing as of 2025)
Table 21. Ranking of Global Top Small Molecule Drug 3D Printing Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Small Molecule Drug 3D Printing Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Small Molecule Drug 3D Printing, Headquarters and Area Served
Table 24. Global Key Players of Small Molecule Drug 3D Printing, Product and Application
Table 25. Global Key Players of Small Molecule Drug 3D Printing, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Small Molecule Drug 3D Printing Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Small Molecule Drug 3D Printing Market Share by Revenue, by Company (2021-2026)
Table 29. North America Small Molecule Drug 3D Printing Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Small Molecule Drug 3D Printing Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Small Molecule Drug 3D Printing Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Small Molecule Drug 3D Printing Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Small Molecule Drug 3D Printing Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Small Molecule Drug 3D Printing Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Small Molecule Drug 3D Printing Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Small Molecule Drug 3D Printing Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Small Molecule Drug 3D Printing Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Small Molecule Drug 3D Printing Market Size by Application (2021-2026) & (US$ Million)
Table 39. Aprecia Company Details
Table 40. Aprecia Business Overview
Table 41. Aprecia Small Molecule Drug 3D Printing Product
Table 42. Aprecia Revenue in Small Molecule Drug 3D Printing Business (2021-2026) & (US$ Million)
Table 43. Aprecia Recent Development
Table 44. FabRx Company Details
Table 45. FabRx Business Overview
Table 46. FabRx Small Molecule Drug 3D Printing Product
Table 47. FabRx Revenue in Small Molecule Drug 3D Printing Business (2021-2026) & (US$ Million)
Table 48. FabRx Recent Development
Table 49. Multiply Labs Company Details
Table 50. Multiply Labs Business Overview
Table 51. Multiply Labs Small Molecule Drug 3D Printing Product
Table 52. Multiply Labs Revenue in Small Molecule Drug 3D Printing Business (2021-2026) & (US$ Million)
Table 53. Multiply Labs Recent Development
Table 54. Merck KGaA Company Details
Table 55. Merck KGaA Business Overview
Table 56. Merck KGaA Small Molecule Drug 3D Printing Product
Table 57. Merck KGaA Revenue in Small Molecule Drug 3D Printing Business (2021-2026) & (US$ Million)
Table 58. Merck KGaA Recent Development
Table 59. Triastek Company Details
Table 60. Triastek Business Overview
Table 61. Triastek Small Molecule Drug 3D Printing Product
Table 62. Triastek Revenue in Small Molecule Drug 3D Printing Business (2021-2026) & (US$ Million)
Table 63. Triastek Recent Development
Table 64. MSD Company Details
Table 65. MSD Business Overview
Table 66. MSD Small Molecule Drug 3D Printing Product
Table 67. MSD Revenue in Small Molecule Drug 3D Printing Business (2021-2026) & (US$ Million)
Table 68. MSD Recent Development
Table 69. AstraZeneca Company Details
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca Small Molecule Drug 3D Printing Product
Table 72. AstraZeneca Revenue in Small Molecule Drug 3D Printing Business (2021-2026) & (US$ Million)
Table 73. AstraZeneca Recent Development
Table 74. TNO Company Details
Table 75. TNO Business Overview
Table 76. TNO Small Molecule Drug 3D Printing Product
Table 77. TNO Revenue in Small Molecule Drug 3D Printing Business (2021-2026) & (US$ Million)
Table 78. TNO Recent Development
Table 79. Multiply Labs Company Details
Table 80. Multiply Labs Business Overview
Table 81. Multiply Labs Small Molecule Drug 3D Printing Product
Table 82. Multiply Labs Revenue in Small Molecule Drug 3D Printing Business (2021-2026) & (US$ Million)
Table 83. Multiply Labs Recent Development
Table 84. DiHeSys Company Details
Table 85. DiHeSys Business Overview
Table 86. DiHeSys Small Molecule Drug 3D Printing Product
Table 87. DiHeSys Revenue in Small Molecule Drug 3D Printing Business (2021-2026) & (US$ Million)
Table 88. DiHeSys Recent Development
Table 89. Small Molecule Drug 3D Printing Market Trends
Table 90. Small Molecule Drug 3D Printing Market Drivers
Table 91. Small Molecule Drug 3D Printing Market Challenges
Table 92. Small Molecule Drug 3D Printing Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources

List of Figures
Figure 1. Small Molecule Drug 3D Printing Product Picture
Figure 2. Global Small Molecule Drug 3D Printing Market Share by Type: 2025 vs 2032
Figure 3. Material Extrusion Features
Figure 4. Binder Jetting Features
Figure 5. Powder Bed Fusion Features
Figure 6. Other Features
Figure 7. Global Small Molecule Drug 3D Printing Market Share by Application: 2025 vs 2032
Figure 8. Large-scale Production
Figure 9. Personalized Pharmaceutical
Figure 10. Concept Research and Technology Development
Figure 11. Small Molecule Drug 3D Printing Report Years Considered
Figure 12. Global Small Molecule Drug 3D Printing Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 13. Global Small Molecule Drug 3D Printing Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Small Molecule Drug 3D Printing Market Share by Revenue, by Region: 2021 vs 2025
Figure 15. North America Small Molecule Drug 3D Printing Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Europe Small Molecule Drug 3D Printing Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Asia-Pacific Small Molecule Drug 3D Printing Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Global Small Molecule Drug 3D Printing Market Share by Players in 2025
Figure 19. Global Top Small Molecule Drug 3D Printing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug 3D Printing as of 2025)
Figure 20. The Top 10 and 5 Players Market Share by Small Molecule Drug 3D Printing Revenue in 2025
Figure 21. North America Small Molecule Drug 3D Printing Market Share by Type (2021-2026)
Figure 22. North America Small Molecule Drug 3D Printing Market Share by Application (2021-2026)
Figure 23. Europe Small Molecule Drug 3D Printing Market Share by Type (2021-2026)
Figure 24. Europe Small Molecule Drug 3D Printing Market Share by Application (2021-2026)
Figure 25. Asia-Pacific Small Molecule Drug 3D Printing Market Share by Type (2021-2026)
Figure 26. Asia-Pacific Small Molecule Drug 3D Printing Market Share by Application (2021-2026)
Figure 27. Aprecia Revenue Growth Rate in Small Molecule Drug 3D Printing Business (2021-2026)
Figure 28. FabRx Revenue Growth Rate in Small Molecule Drug 3D Printing Business (2021-2026)
Figure 29. Multiply Labs Revenue Growth Rate in Small Molecule Drug 3D Printing Business (2021-2026)
Figure 30. Merck KGaA Revenue Growth Rate in Small Molecule Drug 3D Printing Business (2021-2026)
Figure 31. Triastek Revenue Growth Rate in Small Molecule Drug 3D Printing Business (2021-2026)
Figure 32. MSD Revenue Growth Rate in Small Molecule Drug 3D Printing Business (2021-2026)
Figure 33. AstraZeneca Revenue Growth Rate in Small Molecule Drug 3D Printing Business (2021-2026)
Figure 34. TNO Revenue Growth Rate in Small Molecule Drug 3D Printing Business (2021-2026)
Figure 35. Multiply Labs Revenue Growth Rate in Small Molecule Drug 3D Printing Business (2021-2026)
Figure 36. DiHeSys Revenue Growth Rate in Small Molecule Drug 3D Printing Business (2021-2026)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed